Abbott Laboratories (ABT) reported its Q2 2026 financial results on July 16, 2026, before the market open. The company reported earnings per share (EPS) of 1.31 USD, beating the analyst estimate of 1.28 USD by 2.6%. Revenue for the quarter reached 12593 million USD. Following the announcement, the stock price rose by 10.71%.
Generated automatically from our data — as of July 23, 2026
Key figures at a glance
Estimate (EPS): 1.28 USD
Reported (EPS): 1.31 USD
Price reaction: +10.7%
Frequently asked questions
Did Abbott Laboratories beat or miss earnings-per-share expectations?
Abbott Laboratories beat the analyst estimate of 1.28 USD earnings per share (Q2 2026) by 2.6%, reporting 1.31 USD.
How did Abbott Laboratories stock react to the earnings report?
Abbott Laboratories stock rose 10.7% on the trading day following the release.
What was Abbott Laboratories's revenue in Q2 2026?
Abbott Laboratories reported revenue of 12,593M USD in Q2 2026.